[	[	(	O	O	
The	The	DT	B-NP	O	
effect	effect	NN	I-NP	O	
of	of	IN	B-PP	O	
omeprazole	omeprazole	NN	B-NP	O	
on	on	IN	B-PP	O	
healing	healing	NN	B-NP	O	
of	of	IN	B-PP	O	
duodenal	duodenal	JJ	B-NP	O	
ulcers	ulcer	NNS	I-NP	O	
,	,	,	O	O	
Helicobacter pylori	Helicobacter_pylori	NN	B-NP	O	
and	and	CC	O	O	
gastritis	gastritis	NN	B-NP	O	
]	]	)	O	O	
.	.	.	O	O	

Losec	Losec	NN	B-NP	O	
(	(	(	O	O	
omeprazole	omeprazole	NN	B-NP	O	
)	)	)	O	O	
Astra	Astra	NNP	B-NP	O	
Co	Co	NNP	I-NP	O	
.	.	.	O	O	
is	be	VBZ	B-VP	O	
a	a	DT	B-NP	O	
blocker	blocker	NN	I-NP	O	
of	of	IN	B-PP	O	
the	the	DT	B-NP	O	
proton	proton	NN	I-NP	O	
pump	pump	NN	I-NP	O	
of	of	IN	B-PP	O	
the	the	DT	B-NP	O	
parietal	parietal	JJ	I-NP	B-cell_type	
cell	cell	NN	I-NP	I-cell_type	
.	.	.	O	O	

It	It	PRP	B-NP	O	
inhibits	inhibit	VBZ	B-VP	O	
basal	basal	JJ	B-NP	O	
and	and	CC	I-NP	O	
stimulated	stimulate	VBN	I-NP	O	
HCl	HCl	NN	I-NP	O	
secretion	secretion	NN	I-NP	O	
.	.	.	O	O	

It	It	PRP	B-NP	O	
is	be	VBZ	B-VP	O	
used	use	VBN	I-VP	O	
for	for	IN	B-PP	O	
treatment	treatment	NN	B-NP	O	
of	of	IN	B-PP	O	
gastroduodenal	gastroduodenal	JJ	B-NP	O	
ulcers	ulcer	NNS	I-NP	O	
,	,	,	O	O	
reflux	reflux	NN	B-NP	O	
oesophagitis	oesophagitis	NN	I-NP	O	
and	and	CC	I-NP	O	
Zollinger	Zollinger	NN	I-NP	O	
Ellison's	Ellison'	NNS	I-NP	O	
syndrome	syndrome	NN	I-NP	O	
.	.	.	O	O	

In	In	IN	B-PP	O	
a	a	DT	B-NP	O	
group	group	NN	I-NP	O	
of	of	IN	B-PP	O	
17	17	CD	B-NP	O	
patients	patient	NNS	I-NP	O	
with	with	IN	B-PP	O	
duodenal	duodenal	JJ	B-NP	O	
ulcers	ulcer	NNS	I-NP	O	
the	the	DT	B-NP	O	
authors	author	NNS	I-NP	O	
investigated	investigate	VBD	B-VP	O	
the	the	DT	B-NP	O	
effect	effect	NN	I-NP	O	
of	of	IN	B-PP	O	
omeprazole	omeprazole	NN	B-NP	O	
on	on	IN	B-PP	O	
(	(	(	B-LST	O	
1	1	LS	I-LST	O	
)	)	)	O	O	
healing	healing	NN	B-NP	O	
of	of	IN	B-PP	O	
duodenal	duodenal	JJ	B-NP	O	
ulcers	ulcer	NNS	I-NP	O	
and	and	CC	O	O	
bulbitis	bulbitis	NN	B-NP	O	
after	after	IN	B-PP	O	
2-4	2-4	CD	B-NP	O	
weeks	week	NNS	I-NP	O	
of	of	IN	B-PP	O	
therapy	therapy	NN	B-NP	O	
,	,	,	O	O	
(	(	(	B-LST	O	
2	2	LS	I-LST	O	
)	)	)	O	O	
elimination	elimination	NN	B-NP	O	
of	of	IN	B-PP	O	
Helicobacter pylori	Helicobacter_pylori	NNP	B-NP	O	
in	in	IN	B-PP	O	
the	the	DT	B-NP	O	
antrum	antrum	NN	I-NP	O	
,	,	,	O	O	
(	(	(	B-LST	O	
3	3	LS	I-LST	O	
)	)	)	O	O	
chronic	chronic	JJ	B-NP	O	
antral	antral	JJ	I-NP	O	
gastritis	gastritis	NN	I-NP	O	
.	.	.	O	O	

Ad	Ad	NN	B-NP	B-protein	
1	1	CD	I-NP	I-protein	
.	.	.	O	O	

After	After	IN	B-PP	O	
two	two	CD	B-NP	O	
weeks	week	NNS	I-NP	O	
of	of	IN	B-PP	O	
treatment	treatment	NN	B-NP	O	
the	the	DT	B-NP	O	
authors	author	NNS	I-NP	O	
found	find	VBD	B-VP	O	
that	that	IN	B-SBAR	O	
5	5	CD	B-NP	O	
of	of	IN	B-PP	O	
17	17	CD	B-NP	O	
chronic	chronic	JJ	I-NP	O	
duodenal	duodenal	JJ	I-NP	O	
ulcers	ulcer	NNS	I-NP	O	
were	be	VBD	B-VP	O	
healed	heal	VBN	I-VP	O	
in	in	IN	B-PP	O	
the	the	DT	B-NP	O	
remainder	remainder	NN	I-NP	O	
substantial	substantial	JJ	I-NP	O	
regression	regression	NN	I-NP	O	
was	be	VBD	B-VP	O	
found	find	VBN	I-VP	O	
.	.	.	O	O	

Four	Four	CD	B-NP	O	
-	-	HYPH	I-NP	O	
week	week	NN	I-NP	O	
treatment	treatment	NN	I-NP	O	
led	lead	VBD	B-VP	O	
to	to	TO	B-PP	O	
healing	healing	NN	B-NP	O	
of	of	IN	B-PP	O	
16	16	CD	B-NP	O	
from	from	IN	B-PP	O	
a	a	DT	B-NP	O	
total	total	NN	I-NP	O	
of	of	IN	B-PP	O	
17	17	CD	B-NP	O	
ulcers	ulcer	NNS	I-NP	O	
(	(	(	O	O	
P	P	NN	B-NP	O	
<	<	SYM	O	O	
0.001	0.001	CD	B-NP	O	
)	)	)	O	O	
,	,	,	O	O	
i	i	NN	B-NP	O	
.	.	.	O	O	
e	e	NN	B-NP	B-protein	
.	.	.	B-NP	I-protein	
94%	94%	CD	I-NP	I-protein	
.	.	.	O	O	

In	In	IN	B-PP	O	
subjects	subject	NNS	B-NP	O	
with	with	IN	B-PP	O	
ulcers	ulcer	NNS	B-NP	O	
and	and	CC	O	O	
bulbitis	bulbitis	NN	B-NP	O	
(	(	(	O	O	
12	12	CD	B-NP	O	
patients	patient	NNS	I-NP	O	
)	)	)	O	O	
the	the	DT	B-NP	O	
ulcer	ulcer	NN	I-NP	O	
healed	heal	VBD	B-VP	O	
in	in	IN	B-PP	O	
11	11	CD	B-NP	O	
instances	instance	NNS	I-NP	O	
,	,	,	O	O	
in	in	IN	B-PP	O	
7	7	CD	B-NP	O	
patients	patient	NNS	I-NP	O	
residual	residual	JJ	B-NP	O	
bulbitis	bulbitis	NN	I-NP	O	
persisted	persist	VBD	B-VP	O	
.	.	.	O	O	

Ad	Ad	NN	B-NP	B-protein	
2	2	CD	I-NP	I-protein	
.	.	.	O	O	

H. pylori	H._pylori	NN	B-NP	O	
was	be	VBD	B-VP	O	
detected	detect	VBN	I-VP	O	
before	before	IN	B-PP	O	
treatment	treatment	NN	B-NP	O	
in	in	IN	B-PP	O	
16	16	CD	B-NP	O	
of	of	IN	B-PP	O	
17	17	CD	B-NP	O	
patients	patient	NNS	I-NP	O	
,	,	,	O	O	
after	after	IN	B-PP	O	
treatment	treatment	NN	B-NP	O	
only	only	RB	B-PP	O	
in	in	IN	I-PP	O	
5	5	CD	B-NP	O	
(	(	(	O	O	
P	P	NN	B-NP	O	
<	<	SYM	O	O	
0.001	0.001	CD	B-NP	O	
)	)	)	O	O	
.	.	.	O	O	

Ad	Ad	NN	B-NP	B-protein	
3	3	CD	I-NP	I-protein	
.	.	.	O	O	

Chronic	Chronic	JJ	B-NP	O	
gastritis	gastritis	NN	I-NP	O	
was	be	VBD	B-VP	O	
recorded	record	VBN	I-VP	O	
before	before	IN	B-PP	O	
treatment	treatment	NN	B-NP	O	
in	in	IN	B-PP	O	
all	all	DT	B-NP	O	
patients	patient	NNS	I-NP	O	
.	.	.	O	O	

Treatment	Treatment	NN	B-NP	O	
reduced	reduce	VBD	B-VP	O	
its	its	PRP$	B-NP	O	
activity	activity	NN	I-NP	O	
and	and	CC	O	O	
the	the	DT	B-NP	O	
presence	presence	NN	I-NP	O	
of	of	IN	B-PP	O	
H. pylori	H._pylori	NNP	B-NP	O	
.	.	.	O	O	

